US-based diagnostic testing company Daktari Diagnostics raised $15.5m in a series D round co-led by pharmaceutical conglomerate Merck’s Global Health Innovation Fund on Monday.
Real estate loans provider Eastern Capital co-led the round, which also included Partners Innovation Fund, an investment unit belonging to Brigham and Women’s Hospital – the teaching hospital affiliated with Harvard University – and venture firm Norwich Ventures.
Daktari’s diagnostic platform enables molecular tests to be conducted in pharmacies, general practitioners surgeries and remote health facilities.…
